The Discounted Cash Flow (DCF) valuation of Neuropace Inc (NPCE) is (12.15) USD. With the latest stock price at 14.06 USD, the upside of Neuropace Inc based on DCF is -186.4%.
Based on the latest price of 14.06 USD and our DCF valuation, Neuropace Inc (NPCE) is a sell. selling NPCE stocks now will result in a potential gain of 186.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.8% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (26.62) - (8.39) | (12.15) |
| Upside | -289.3% - -159.6% | -186.4% |